News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,477 Results
Type
Article (14098)
Company Profile (283)
Press Release (250096)
Section
Business (79454)
Career Advice (152)
Deals (13219)
Drug Delivery (35)
Drug Development (50395)
Employer Resources (31)
FDA (5702)
Job Trends (5124)
News (144288)
Policy (10024)
Tag
Academia (905)
Alliances (21605)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5704)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4560)
Biotechnology (233)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40556)
Collaboration (436)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1150)
Diabetes (105)
Diagnostics (1278)
Earnings (29209)
Events (47656)
Executive appointments (353)
FDA (6208)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (338)
Government (1071)
Healthcare (6569)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7247)
Job creations (859)
Job search strategy (127)
Layoffs (196)
Legal (1383)
Lung cancer (164)
Manufacturing (103)
Medical device (2576)
Medtech (2577)
Mergers & acquisitions (6206)
Metabolic disorders (315)
Neuroscience (1108)
NextGen: Class of 2025 (2012)
Non-profit (852)
Northern California (1339)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25353)
Phase I (14314)
Phase II (18873)
Phase III (11920)
Pipeline (504)
Postmarket research (852)
Preclinical (5996)
Radiopharmaceuticals (209)
Rare diseases (248)
Real estate (1414)
Regulatory (8438)
Research institute (932)
Series A (82)
Southern California (1188)
Startups (1968)
United States (10533)
Vaccines (189)
Weight loss (96)
Date
Last 7 days (339)
Last 30 days (1438)
Last 365 days (20374)
2025 (2645)
2024 (20553)
2023 (22415)
2022 (26824)
2021 (27805)
2020 (23359)
2019 (16223)
2018 (11739)
2017 (13745)
2016 (11840)
2015 (14350)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Asia (17095)
Australia (2893)
California (3047)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36776)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (397)
Massachusetts (2385)
Minnesota (119)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1339)
Ohio (98)
Pennsylvania (577)
South America (207)
Southern California (1188)
Texas (337)
Washington State (291)
264,477 Results for "quince therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Press Releases
Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
February 7, 2025
·
7 min read
Press Releases
Quince Therapeutics Appoints Renowned Pediatric Neurologist Dr. William Whitehouse to Scientific Advisory Board
January 23, 2025
·
5 min read
Press Releases
Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
January 27, 2025
·
8 min read
Press Releases
Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
January 28, 2025
·
2 min read
Biotech Bay
Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
Quince Therapeutics, Inc. (Nasdaq: QNCX) today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will present at The Citizens JMP Life Sciences Conference on Monday, May 13, 2024 beginning at 1:30 p.m. Eastern Time.
May 6, 2024
·
1 min read
Business
Quince Therapeutics Launches Scientific Advisory Board
Quince Therapeutics, Inc. today announced the launch of a Scientific Advisory Board.
February 22, 2024
·
12 min read
Press Releases
Quince Therapeutics to Participate at Upcoming October 2024 Investor Conferences
October 15, 2024
·
1 min read
Press Releases
Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
November 14, 2024
·
8 min read
Business
Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Quince Therapeutics, Inc. provided an update on the company’s development pipeline and reported financial results for the first quarter ended March 31, 2024.
May 13, 2024
·
9 min read
1 of 26,448
Next
